Ignite Creation Date:
2024-05-05 @ 4:55 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00346684
Status:
COMPLETED
Last Update Posted:
2008-08-12
First Post:
2006-06-29
Brief Title:
Rituximab in Primary Lymphocyte Predominant Hodgkins DiseaseRIPL
Sponsor:
University of Cologne
Organization:
University of Cologne
Organization Data
Organization:
University of Cologne
Class:
OTHER
Study ID:
RIPL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Cologne
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None